Breathe Well Live Well
 MD News (press release) |
Pediatric Asthma Drug Prescriptions on the Upswing
MD News (press release) Among children, the use of medications to control asthma nearly doubled in the last decade, while costs associated with all asthma medications more than quadrupled, according to a September statistical brief published by the Agency for Healthcare … |
View full post on asthma – Google News
|
Kissei funds for MediciNova asthma drug development
Pharmaceutical Business Review Kissei Pharmaceutical is funding $2.5m to support further clinical development of MediciNova's MN-221 to treat acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD). As per the license agreenent signed between the two companies … MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd … Kissei To Pay MediciNova $2.5 Mln To Support Clinical Development Of MN-221 MediciNova Inc expects USD2.5m from Kissei Pharmaceutical Co Ltd for MN-221 … |
View full post on asthma – Google News
|
Asthma Drug May Boost Failing
Leadership Newspapers A drug used to treat asthma may be a new way to tackle heart failure. It works by boosting the heart's action, helping it pump faster. About 900000 Britons – most of them older people – suffer from heart failure, with the condition more common in men. … |
View full post on asthma – Google News
|
DR. LINDA JOHNSON: Khella is natural asthma 'drug'
Alamogordo Daily News Dealing with asthma is a little like having to breathe through a straw. It turns out that every breath we take is a memorable event when we have to work for it, which is why most asthma sufferers keep their stash of meds close. … |
View full post on asthma – Google News
 HealthNewsDigest.com |
Asthma Drug Spending Soars in US
National Journal US spending on asthma drugs more than quadrupled from $527 million to $2.5 billion in the 10 years from 1998 to 2008, according to government figures released on Wednesday. Much of the reason is clear. The proportion of children who used … Children's Use of Asthma Controller Drugs Doubles |
View full post on asthma – Google News
 Daily Mail |
The asthma drug that boosts failing hearts by helping it to pump faster
Daily Mail A drug used to treat asthma may be a new way to tackle heart failure. It works by boosting the heart's action, helping it pump faster. About 900000 Britons — most of them older people — suffer from heart failure, with the condition more … |
View full post on asthma – Google News
HealthDay – WEDNESDAY, Sept. 28 (HealthDay News) — About one in six asthma
sufferers carries a genetic variant that’s associated with a poor response
to commonly prescribed inhaled asthma medications called corticosteroids,
according to a new study.
View full post on Yahoo! News: Health News
 Proactive Investors USA & Canada |
AstraZeneca Pays Dynavax $3M to Speed Up Start of Asthma Drug Trials
Genetic Engineering News Dynavax Technologies will receive a $3 million payment from AstraZeneca to fund the initiation of clinical trials with their partnered asthma drug AZD 1419. The payment comes as part of the firms' amended collaboration to accelerate the start of … AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug Dynavax and AstraZeneca to Advance TLR-9 Agonist Into Clinic for Asthma Dynavax Technologies Corporation partners with AstraZeneca to advance AZD 1419 … |
View full post on asthma – Google News
Proactive Investors USA & Canada |
AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug
Proactive Investors USA & Canada AstraZeneca (NYSE:AZN) and Dynavax Technologies (NASDAQ:DVAX) announced Wednesday they have amended their collaboration agreement so as to accelerate the development of AZD1419, intended for the treatment of asthma. Under the terms of the agreement, … Dynavax and AstraZeneca to Advance TLR-9 Agonist Into Clinic for Asthma Dynavax gets $3M in reworked asthma deal with AstraZeneca |
View full post on asthma – Google News
|
Study: Asthma, COPD markets to see revenue growth, innovation
Drug Store News Growing numbers of Americans with asthma and chronic obstructive pulmonary disease are driving innovation among drug makers, according to a new report by Frost & Sullivan. More than 40 million Americans were diagnosed with asthma or COPD in 2009, … Asthma and COPD Therapies: World Market 2011-2021 Asthma and COPD Therapies: World Market 2011-2021 |
View full post on asthma – Google News